Research location
Brighton
Massachusetts, United States
Advertisement
Research activity in Brighton
Massachusetts, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 80 trials and 80 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Brighton
80 linked trials · page 1 of 2EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx PopulationsNCT06716580 · 2025-04-01 · 1 site observation
RECRUITING
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)NCT06857942 · 2025-03-19 · 1 site observation
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514 · 2025-02-27 · 1 site observation
RECRUITING
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844 · 2024-07-19 · 1 site observation
RECRUITING
Alleviant ALLAY-HF StudyNCT05685303 · 2023-01-10 · 1 site observation
RECRUITING
ATEMPT 2.0: Adjuvant T-DM1 vs THNCT04893109 · 2021-06-16 · 1 site observation
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7NCT04613596 · 2020-12-02 · 1 site observation
RECRUITING
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])NCT04267848 · 2020-06-16 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)NCT06516965 · 2024-10-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's DiseaseNCT06107426 · 2024-01-24 · 1 site observation
ACTIVE_NOT_RECRUITING
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast CancerNCT06001762 · 2023-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)NCT05555732 · 2023-01-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Culturally Aware AET Non-Initiation InterventionNCT05465408 · 2022-07-21 · 1 site observation
COMPLETED
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseNCT04750226 · 2021-02-18 · 1 site observation
COMPLETED
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate CancersNCT04330716 · 2020-12-01 · 1 site observation
COMPLETED
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseNCT04380142 · 2020-10-19 · 1 site observation
COMPLETED
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstateNCT04136353 · 2020-03-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Plasma-Adapted First-Line Pembro In NSCLCNCT04166487 · 2020-01-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)NCT03811002 · 2019-07-26 · 1 site observation
ACTIVE_NOT_RECRUITING
ATOP TRIAL: T-DM1 in HER2 Positive Breast CancerNCT03587740 · 2018-08-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast CancerNCT03633331 · 2018-08-15 · 1 site observation
COMPLETED
Clinical Utility of Subcutaneous Furosemide in Patients Presenting With Early Signs of Fluid OverloadNCT03359161 · 2018-04-05 · 1 site observation
TERMINATED
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEFNCT03043651 · 2018-01-30 · 1 site observation
TERMINATED
Phrenic Nerve Stimulation for Treatment of Central Sleep ApneaNCT03238937 · 2017-10-05 · 1 site observation
WITHDRAWN
Palbociclib After CDK and Endocrine Therapy (PACE)NCT03147287 · 2017-09-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionNCT03037580 · 2017-08-15 · 1 site observation
TERMINATED
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation TherapyNCT02927249 · 2017-01-06 · 1 site observation
TERMINATED
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerNCT02744092 · 2016-12-13 · 1 site observation
COMPLETED
Breast Cancer WEight Loss Study (BWEL Study)NCT02750826 · 2016-09-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)NCT02595944 · 2016-07-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Baroreflex Activation Therapy for Heart FailureNCT02627196 · 2016-04-19 · 1 site observation
COMPLETED
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®NCT02823951 · 2016-02-01 · 1 site observation
COMPLETED
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone TherapyNCT01598298 · 2013-05-15 · 1 site observation
COMPLETED
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerNCT01809691 · 2013-03-08 · 1 site observation
COMPLETED
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic NeuropathyNCT01770964 · 2012-12-01 · 1 site observation
UNKNOWN
BAROSTIM® Hope for Heart Failure StudyNCT01720160 · 2012-11-01 · 1 site observation
UNKNOWN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerNCT01097278 · 2011-11-01 · 1 site observation
COMPLETED
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin MonotherapyNCT01514149 · 2011-09-01 · 1 site observation
TERMINATED
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5CNCT01381172 · 2011-01-01 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)NCT01110902 · 2010-05-01 · 1 site observation
COMPLETED
JC-Virus (JCV) Antibody ProgramNCT01070823 · 2010-03-01 · 1 site observation
COMPLETED
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerNCT01041781 · 2010-02-01 · 1 site observation
TERMINATED
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing ChemoNCT00775645 · 2009-09-01 · 1 site observation
COMPLETED
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerNCT00946712 · 2009-07-15 · 1 site observation
TERMINATED
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerNCT00942331 · 2009-07-15 · 1 site observation
COMPLETED
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementNCT00869206 · 2009-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.